2024/10/31 21:00:02 | |
---|---|
Price | |
113.37 USD | |
Difference | -0.94% (-1.08) |
ISIN | US0028241000 |
Symbol | ABT |
Exchange | NYSE |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 181,240 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 119.01 USD (500) |
Ask (Ask size) | 119.48 USD (200) |
Open | 113.57 USD |
High | 114.47 USD |
Low | 113.27 USD |
Close (prev. day) | 114.45 USD |
VWAP | 114.035011 USD |
Volume (pcs) | 5,323,165 |
Trading volume | 606,852,202.55 |
Number of trades | 60,547 |
Last size | - |
Related Futures | 15 |
Related Options | - |
Date | Headline | Download | |
2024/10/29 | Global Equity Ratings | ||
2024/10/29 | Aktienempfehlungen Global | ||
2024/10/22 | Global Equity Ratings | ||
2024/10/22 | Aktienempfehlungen Global | ||
2024/09/27 | Global Equity Ratings |
2024/10/31 21:00:02 | |
---|---|
Price | |
113.37 USD | |
Difference | -0.94% (-1.08) |
ISIN | US0028241000 |
Symbol | ABT |
Exchange | NYSE |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 181,240 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 119.01 USD (500) |
Ask (Ask size) | 119.48 USD (200) |
Open | 113.57 USD |
High | 114.47 USD |
Low | 113.27 USD |
Close (prev. day) | 114.45 USD |
VWAP | 114.035011 USD |
Volume (pcs) | 5,323,165 |
Trading volume | 606,852,202.55 |
Number of trades | 60,547 |
Last size | - |
6M | 1Y | 3Y | |
Perf (%) | +5.59% | +17.16% | -5.71% |
Perf (abs.) | +5.55 | +15.35 | -6.35 |
Beta | 0.01 | 0.23 | 0.68 |
Volatility | 17.95 | 17.75 | 21.53 |
Ø price 5 days | Ø volume 5 days (pcs.) | 113.90 USD (5,029,818) |
Ø price 30 days | Ø volume 30 days (pcs.) | 114.87 USD (4,997,256) |
Ø price 100 days | Ø volume 100 days (pcs.) | 110.33 USD (5,725,645) |
Ø price 250 days | Ø volume 250 days (pcs.) | 109.48 USD (5,667,153) |
YTD High | date | 121.64 USD (2024/03/08) |
YTD Low | date | 99.71 USD (2024/07/18) |
52 Weeks High | date | 121.64 USD (2024/03/08) |
52 Weeks Low | date | 92.43 USD (2023/11/10) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Xetra | 2024/10/31 | 17:35 | 104.92 EUR | 0.15 | 29 |
Vienna Stock Exchange | 2024/10/31 | 17:32 | 104.88 EUR | 0.01 | 6 |
Tradegate | 2024/11/01 | 08:00 | 109.00 EUR | 0.00 | 1 |
Stuttgart | 2024/10/31 | 20:43 | 104.26 EUR | 0.00 | 4 |
SIX Swiss Exchange | 2024/09/30 | 09:05 | 93.50 CHF | 0.00 | 1 |
NYSE | 2024/10/31 | 21:00 | 113.37 USD | 606.85 | 60,547 |
Munich | 2024/11/01 | 08:02 | 108.58 EUR | 0.00 | 1 |
London Stock Exchange | 2024/10/22 | 17:13 | 116.61 USD | 0.04 | 1 |
Hanover | 2024/11/01 | 08:10 | 109.02 EUR | 0.00 | 1 |
Hamburg | 2024/11/01 | 08:01 | 109.00 EUR | 0.00 | 1 |
Frankfurt | 2024/11/01 | 08:03 | 109.02 EUR | 0.00 | 1 |
Duesseldorf | 2024/11/01 | 08:10 | 108.98 EUR | 0.00 | 1 |
Berlin | 2024/11/01 | 08:09 | 109.32 EUR | 0.00 | 1 |
ABBOTT LABORATORIES |
- - |
100 Abbott Park Road - 60064-6400 Abbott Park |
Telefon: +1-224-667-6100 |
Fax: + |
E-mail: - |
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL. |
Robert Alpern | Member of Board of Directors |
Sally Blount | Member of Board of Directors |
Claire Babineaux-Fontenot | Member of Board of Directors |
Daniel Starks | Member of Board of Directors |
Darren McDew | Member of Board of Directors |
John Stratton | Member of Board of Directors |
Michael O'Grady | Member of Board of Directors |
Michael Roman | Member of Board of Directors |
Michelle Kumbier | Member of Board of Directors |
Nancy McKinstry | Member of Board of Directors |
Paola Gonzalez | Member of Board of Directors |
Robert B. Ford | Chairman of Managing Board |
Andrea F. Wainer | Member of Executive Committee |
Daniel Salvadori | Member of Executive Committee |
Hubert L. Allen | Member of Executive Committee |
Lisa D. Earnhardt | Member of Executive Committee |
Mary K. Moreland | Member of Executive Committee |
Robert E. Funck, Jr. | Member of Executive Committee |
Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).
The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.
Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.
The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.
By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.